907 related articles for article (PubMed ID: 10766989)
21. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
[TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.
Lindsay EA; Halford S; Wadey R; Scambler PJ; Baldini A
Genomics; 1993 Aug; 17(2):403-7. PubMed ID: 8406492
[TBL] [Abstract][Full Text] [Related]
23. 1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features.
Alberti A; Romano C; Falco M; Calì F; Schinocca P; Galesi O; Spalletta A; Di Benedetto D; Fichera M
Clin Genet; 2007 Feb; 71(2):177-82. PubMed ID: 17250668
[TBL] [Abstract][Full Text] [Related]
24. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
Oh AK; Workman LA; Wong GB
Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
[TBL] [Abstract][Full Text] [Related]
25. Computational analysis and refinement of sequence structure on chromosome 22q11.2 region: application to the development of quantitative real-time PCR assay for clinical diagnosis.
Chen YF; Kou PL; Tsai SJ; Chen KF; Chan HH; Chen CM; Sun HS
Genomics; 2006 Feb; 87(2):290-7. PubMed ID: 16307865
[TBL] [Abstract][Full Text] [Related]
26. [Improvement of genetic diagnostic strategy in velo-cardio-facial syndrome].
Pânzaru M; Rusu C; Voloşciuc M; Braha E; Butnariu L; Ivanov I; Grămescu M; Popescu R; Caba L; Sireteanu A; Macovei M; Covic M; Gorduza EV
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):756-61. PubMed ID: 22046783
[TBL] [Abstract][Full Text] [Related]
27. Inherited t(9;22) as the cause of DiGeorge syndrome: a case report.
Shuib S; Abdul Latif Z; Abidin NZ; Akmal SN; Zakaria Z
Malays J Pathol; 2009 Dec; 31(2):133-6. PubMed ID: 20514857
[TBL] [Abstract][Full Text] [Related]
28. [Study on clinical features and fluorescence in situ hybridization detections of 22q11 microdeletion syndrome].
Qin YF; Yang JB; Xie CH; Shao J; Zhao ZY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):284-7. PubMed ID: 17557238
[TBL] [Abstract][Full Text] [Related]
29. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.
Driscoll DA; Spinner NB; Budarf ML; McDonald-McGinn DM; Zackai EH; Goldberg RB; Shprintzen RJ; Saal HM; Zonana J; Jones MC
Am J Med Genet; 1992 Sep; 44(2):261-8. PubMed ID: 1360769
[TBL] [Abstract][Full Text] [Related]
30. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
[TBL] [Abstract][Full Text] [Related]
31. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome.
Guris DL; Fantes J; Tara D; Druker BJ; Imamoto A
Nat Genet; 2001 Mar; 27(3):293-8. PubMed ID: 11242111
[TBL] [Abstract][Full Text] [Related]
32. Deletion of 22q11 in two brothers with different phenotype.
Kasprzak L; Der Kaloustian VM; Elliott AM; Shevell M; Lejtenyi C; Eydoux P
Am J Med Genet; 1998 Jan; 75(3):288-91. PubMed ID: 9475599
[TBL] [Abstract][Full Text] [Related]
33. Molecular cytogenetic characterization of a 10p14 deletion that includes the DGS2 region in a patient with multiple anomalies.
Skrypnyk C; Goecke TO; Majewski F; Bartsch O
Am J Med Genet; 2002 Nov; 113(2):207-12. PubMed ID: 12407714
[TBL] [Abstract][Full Text] [Related]
34. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
Wulfsberg EA
Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
[No Abstract] [Full Text] [Related]
35. Cardiac Registry screening for DiGeorge Critical Region deletion using loss of heterozygosity analysis.
Katzman PJ; Smoot LB; Cox GF
Pediatr Dev Pathol; 2006; 9(4):266-79. PubMed ID: 16944986
[TBL] [Abstract][Full Text] [Related]
36. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients.
Ford LC; Sulprizio SL; Rasgon BM
Laryngoscope; 2000 Mar; 110(3 Pt 1):362-7. PubMed ID: 10718420
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic analysis of the DiGeorge syndrome among Korean patients with congenital heart disease.
Hur H; Kim YJ; Noh CI; Seo JW; Kim MH
Mol Cells; 1999 Feb; 9(1):72-7. PubMed ID: 10102575
[TBL] [Abstract][Full Text] [Related]
38. Prenatal detection and characterization of a small supernumerary marker chromosome (sSMC) derived from chromosome 22 with apparently normal phenotype.
Lin CC; Hsieh YY; Wang CH; Li YC; Hsieh LJ; Lee CC; Tsai CH; Tsai FJ
Prenat Diagn; 2006 Oct; 26(10):898-902. PubMed ID: 16915592
[TBL] [Abstract][Full Text] [Related]
39. DiGeorge/velocardiofacial syndrome: FISH studies of chromosomes 22q11 and 10p14, and clinical reports on the proximal 22q11 deletion.
Bartsch O; Nemecková M; Kocárek E; Wagner A; Puchmajerová A; Poppe M; Ounap K; Goetz P
Am J Med Genet A; 2003 Feb; 117A(1):1-5. PubMed ID: 12548732
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
Driscoll DA; Salvin J; Sellinger B; Budarf ML; McDonald-McGinn DM; Zackai EH; Emanuel BS
J Med Genet; 1993 Oct; 30(10):813-7. PubMed ID: 8230155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
